RECOMBINANT CYTOKINES IN THE TREATMENT OF PNEUMONIA. CLINICAL EXPERIENCE
Antimicrobial chemotherapy is a keystone of the treatment of pneumonia. Prescription of antibacterial drugs does not always ensure the success of treatment due to the secondary immune deficiency developing in the process of the disease and the rapid growthof acquired antibiotic resistance. The art...
Main Authors: | O.A. Gizinger, V.N. Egorova, V.I. Trofimov |
---|---|
Format: | Article |
Language: | English |
Published: |
Al-Farabi Kazakh National University
2021-07-01
|
Series: | Interdisciplinary Approaches to Medicine |
Subjects: | |
Online Access: | https://appmed.kaznu.kz/index.php/medicine/article/view/49/36 |
Similar Items
-
RECOMBINANT CYTOKINES IN THE TREATMENT OF PNEUMONIA. CLINICAL EXPERIENCE
by: O.A. Gizinger, et al.
Published: (2021-06-01) -
Characteristics of Immunocytes and Cytokines in Patients with Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae in China
by: Guo W, et al.
Published: (2024-02-01) -
Relationship between serum TNF-α, IL-6, and IL-
10 levels and disease severity, and changes in the
cytokines after treatment in patients with bacterial
community-acquired pneumonia
by: Bang Ngoc Dao*, et al.
Published: (2023-10-01) -
Etiology and Cytokine Expression in Patients Requiring Mechanical Ventilation Due to Severe Community-acquired Pneumonia
by: Chieh-Liang Wu, et al.
Published: (2006-01-01) -
The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia
by: Fortunato Vesce, et al.
Published: (2022-03-01)